FINWIRES · TerminalLIVE
FINWIRES

Janux Therapeutics Lacking Near-Term Catalysts, UBS Says

By

Janux Therapeutics (JANX) lacks near-term stock-moving catalysts after the stock came under pressure following mixed results from phase 1a trial of JANX007 in 5L metastatic prostate cancer, UBS said in a Wednesday report.

The report said focus will now be on the phase 1b update in taxane-naive metastatic castration-resistant prostate cancer population in H2, with upside depending on whether the data showing a clean safety profile and durable radiographic progression-free survival compared with Pluvicto.

"We think 2H26 data will likely be incremental with limited impact on the stock," the note said, given among others that that the trial is in dose optimization.

The report said a more substantial update may be in 2027, when

more patients from expansion cohorts and more mature follow-up are expected.

UBS downgraded the stock to neutral from buy and lowered its price target to $15 from $57.

Price: $14.77, Change: $-0.47, Percent Change: -3.08%

Related Articles

Wire

GitLab Broadens Google Cloud Collaboration to Support AI Agents

GitLab (GTLB) said late Tuesday it expanded its collaboration with Alphabet's (GOOGL, GOOG) Google Cloud, allowing customers to use Google's Vertex AI models to power the GitLab Duo Agent Platform.The integration lets joint customers call Google's AI models directly inside GitLab, with that usage counting toward their existing Google Cloud spending commitments. GitLab said the move pairs Google's model performance with GitLab's built-in security, compliance and audit controls.GitLab shares rose 6.5% in after-hours trading, and Alphabet was little changed.

$GOOG$GOOGL$GTLB
Wire

TeraWulf Preliminary Q1 Revenue Misses Estimates; $800 Million Stock Offering Planned

TeraWulf (WULF) reported preliminary Q1 revenue late Tuesday of $30 million to $35 million and adjusted EBITDA of breakeven to $3 million.Analysts polled by FactSet expect revenue of $37.5 million and EBITDA of $7.6 million.Separately, the company announced an $800 million offering of common shares with underwriters granted a 30-day option to buy up to an additional $120 million in stock.Net proceeds will be used in part to finance a portion of the construction of a data center at its site in Hawesville, Kentucky.TeraWulf shares fell 7.3% in after-hours trading.

$WULF
Wire

Equity Bancshares Q1 Core EPS, Revenue Rise; Shares Fall After Hours

Equity Bancshares (EQBK) reported Q1 core earnings late Tuesday of $1.32 per diluted share, up from $0.90 a year earlier.Analysts polled by FactSet expected $1.16.Revenue in the three months ended March 31, expressed as the sum of net interest income and total noninterest income, rose to $83.2 million from $60.6 million a year earlier.Four analysts surveyed by FactSet expected $82.7 million.The company's shares fell 4.1% in after-hours trading.

$EQBK